Description
2023 Board Review and Update of Cardiovascular CT Course
Purpose/Desired Learning OutcomeÂ
2023 Board Review and Update of Cardiovascular CT Course After participating in this activity, the participants should be better able to describe the principles of cardiovascular CT scanning, acquisition, and image reconstruction to colleagues and members of the cardiovascular CT team. Implement protocols for decreasing radiation dose while maintaining diagnostic image quality to members of the cardiovascular CT team. Understand the indications, contraindications, capabilities, and limitations of cardiovascular CT in the care of cardiovascular patients. Discuss criteria with colleagues for appropriate selection of patients for cardiovascular CT Identify common pathology that is diagnosed by cardiovascular CT, and distinguish true pathology from artifacts and pitfalls.Â
Videos+Slides +PDF pack of 13 PDFs+Questions
ACCME Accreditation StatementÂ
The Society of Cardiovascular Computed Tomography (SCCT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Â
AMA Credit Designation StatementÂ
The Society of Cardiovascular Computed Tomography (SCCT) designates this enduring material for a maximum of 15.75 AMA PRA Category 1 Credit (s)â„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Â
 Instructions for Claiming CMEÂ
- Complete the sessions in full for which credit is soughtÂ
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted in your professional development journal.Â
Disclosure of Commercial SupportÂ
No commercial or in-kind support was received for this activity.Â
BibliographyÂ
If references were cited, they will appear on the individual presentation slides.Â
Disclosure of Financial RelationshipsÂ
The planners and faculty for this activity did not have any relevant relationships with ACCME- defined ineligible companies to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to The Standards for Integrity and Independence in Accredited Continuing Education.Â
Name of Individual | Individual’s Role(s) in ActivityÂ
(e.g. Planner, Reviewer, Speaker, Author, Moderator, Panelist) |
Name of Ineligible Company(s) | Nature of Relevant Financial Relationship(s) |
Koen Nieman | Planner/Speaker | 1)Siemens 2)Bayer 3)HeartFlow 4)Novartis | 1-3)Grants and research support; 4)Consultant/Honoraria |
Cristina Fuss | Planner/Speaker | Siemens | Consultant/Honoraria |
Milind Desai | Speaker | 1) Medtronic 2)Myokardia | 1)Consultant/Honoraria 2)Grants and research support |
Michelle Williams | Speaker | 1)Canon Medical Systems 2)Siemens Healthineers 3)Norvartis | 1-3)Speaker bureau |
J. Jeffrey Carr | Speaker | 1)IBM Watson Health 2)Varian-Siemens 3)GE Healthcare | 1-3)Grants and research support |
Armin A. Zadeh | Speaker | Canon Medical Systems | Research Grant |
TOPICS